Ingevity Corp
Ingevity develops, manufactures and sells specialty materials and technologies for customers in automotive, filtration, road construction, agriculture and other markets. It is headquartered in North Charleston, South Carolina. Its three segments are Performance Materials, Performance Chemicals and Advanced Polymer Technologies. Performance Materials makes hardwood-based activated carbon, used mainly in vehicle gasoline vapor emission control systems and also in food, water, beverage and chemical purification. Performance Chemicals supplies pavement additives and technologies for asphalt construction, preservation, reconstruction and recycling, agrochemical dispersants, and road marking products. Advanced Polymer Technologies produces caprolactone and caprolactone-based specialty polymers for coatings, resins, elastomers, adhesives, bioplastics and medical applications. Ingevity makes money by selling these products to customers globally, through direct sales representatives and, for some product lines, third-party distributors and representatives. Its products include Evotherm warm mix asphalt technology and Capa specialty polymers.
No SEC Form 4 filings for $NGVT in the last 30 days.
See all $NGVT insider activity →Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.
Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.
Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning NGVT (Ingevity Corp). Coverage has skewed bullish: 2 bullish, 4 neutral, and 1 bearish.
Recent NGVT coverage spans earnings and insider activity.
Guidance lift suggests higher future earnings, likely supporting the stock price.
Earnings guidance remains flat, but share buyback signals confidence; market may view as neutral to slightly positive.
Earnings miss and lower guidance may weigh on the stock.
Guidance lift suggests stronger earnings momentum, supporting a bullish outlook.
This is an insider sale, not a fundamental update, but it can modestly affect near-term sentiment and positioning.
AlphAI scores every news story that mentions NGVT with an AI model for sentiment and relevance, and aggregates insider trades from Ingevity Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.
Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.
Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.
Ingevity Corp (NGVT) shares rose 19.2% YTD, outperforming its industry. The company's portfolio optimization, higher-margin businesses, and demand for hybrid vehicle applications drove growth. Q2 adjusted EBITDA increased 14% YoY to $115M, and 2026 guidance was raised to $380-$400M. NGVT holds a Zacks Rank #2 (Buy).
Li David H (President & CEO) sold 10,092 shares of Ingevity Corp (NGVT) at an average of $75.77 ($74.71–$75.83, $0.76M total) across 3 trades over 2026-08-14 to 2026-08-18 under a Rule 10b5-1 trading plan.
Li David H (President & CEO) sold 10,000 shares of Ingevity Corp (NGVT) at an average of $76.18 ($75.73–$76.62, $0.76M total) across 2 trades over 2026-08-12 to 2026-08-13 under a Rule 10b5-1 trading plan.
Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.
Fisher Ryan C. (SVP, Gen. Counsel & Secretary) sold 2,709 shares of Ingevity Corp (NGVT) at an average of $73.72 ($73.67–$73.76, $0.20M total) across 2 trades on 2026-08-03.
Ingevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.
Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $314.1 million decreased 5% from prior year; exc
